To investigate the role that homeobox genes play in oncogenesis, our group and collaborators have recently identified EMX2 as being epigenetically down-regulated and serving as a putative novel tumor suppressor in lung adenocarcinomas and gastric cancer [16–18]. This evidence concerns the gene EMX2 and neoplasm.